Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Peters

Showing results (141-150 of 168) with videos related to

Pageof 17
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 2, 2024
Decentralized clinical trials for medications to reduce the risk of dementia: Consensus report and guidanceLeanne Howard, Carla Abdelnour, Erin L Abner, et al.
European Heart Journal|October 25, 2022
Blood pressure lowering and prevention of dementia: an individual patient data meta-analysisRuth Peters, Ying Xu, Oisin Fitzgerald, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 22, 2021
Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factorsRuth Peters, John Breitner, Sarah James, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 30, 2021
Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus reportGreg A Jicha, Erin L Abner, Steven E Arnold, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 23, 2023
Higher systolic blood pressure in early-mid adulthood is associated with poorer cognitive performance in those with a dominantly inherited Alzheimer's disease mutation but not in non-carriers. Results from the DIAN studyYing Xu, Htein Linn Aung, Randall J Bateman, et al.
JAMA Internal Medicine|September 6, 2017
Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysisRakesh Malhotra, Hoang Anh Nguyen, Oscar Benavente, et al.
The Lancet. Healthy Longevity|April 28, 2025
Combined mind-body physical exercise, cognitive training, and nurse-led risk factor modification to enhance cognition among older adults with mild cognitive impairment in primary care: a three-arm randomised controlled trialZijun Xu, Dexing Zhang, Benjamin Hon-Kei Yip, et al.
BMJ (Clinical Research Ed.)|March 25, 2025
Effects of intensive blood pressure treatment on orthostatic hypertension: individual level meta-analysisStephen P Juraschek, Jiun-Ruey Hu, Jennifer L Cluett, et al.
BMC Medicine|February 12, 2025
Healthy lifestyle factors and combined macrovascular and microvascular events in diabetes patients with high cardiovascular risk: results from ADVANCEShoujiang You, Danni Zheng, Yanan Wang, et al.
Hypertension (Dallas, Tex. : 1979)|September 20, 2021
Association Between Blood Pressure Variability With Dementia and Cognitive Impairment: A Systematic Review and Meta-AnalysisRianne A A de Heus, Christophe Tzourio, Emily Jo Lynn Lee, et al.
Pageof 17

Showing results (141-150 of 168) with videos related to

Sort By:
Pageof 17
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 2, 2024
Decentralized clinical trials for medications to reduce the risk of dementia: Consensus report and guidanceLeanne Howard, Carla Abdelnour, Erin L Abner, et al.
European Heart Journal|October 25, 2022
Blood pressure lowering and prevention of dementia: an individual patient data meta-analysisRuth Peters, Ying Xu, Oisin Fitzgerald, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 22, 2021
Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factorsRuth Peters, John Breitner, Sarah James, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 30, 2021
Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus reportGreg A Jicha, Erin L Abner, Steven E Arnold, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 23, 2023
Higher systolic blood pressure in early-mid adulthood is associated with poorer cognitive performance in those with a dominantly inherited Alzheimer's disease mutation but not in non-carriers. Results from the DIAN studyYing Xu, Htein Linn Aung, Randall J Bateman, et al.
JAMA Internal Medicine|September 6, 2017
Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysisRakesh Malhotra, Hoang Anh Nguyen, Oscar Benavente, et al.
The Lancet. Healthy Longevity|April 28, 2025
Combined mind-body physical exercise, cognitive training, and nurse-led risk factor modification to enhance cognition among older adults with mild cognitive impairment in primary care: a three-arm randomised controlled trialZijun Xu, Dexing Zhang, Benjamin Hon-Kei Yip, et al.
BMJ (Clinical Research Ed.)|March 25, 2025
Effects of intensive blood pressure treatment on orthostatic hypertension: individual level meta-analysisStephen P Juraschek, Jiun-Ruey Hu, Jennifer L Cluett, et al.
BMC Medicine|February 12, 2025
Healthy lifestyle factors and combined macrovascular and microvascular events in diabetes patients with high cardiovascular risk: results from ADVANCEShoujiang You, Danni Zheng, Yanan Wang, et al.
Hypertension (Dallas, Tex. : 1979)|September 20, 2021
Association Between Blood Pressure Variability With Dementia and Cognitive Impairment: A Systematic Review and Meta-AnalysisRianne A A de Heus, Christophe Tzourio, Emily Jo Lynn Lee, et al.
Pageof 17